Impact Factor 4.137 | CiteScore 4.28
More on impact ›

Case Report ARTICLE Provisionally accepted The full-text will be published soon. Notify me

Front. Oncol. | doi: 10.3389/fonc.2019.00828

Recurrent glioma with lineage conversion from oligodendroglioma to astrocytoma in two cases

Jo-Heon Kim Kim1, Woo-Youl Jang Jang1,  Tae-Young Jung1, Shin Jung1, Kyung-Keun Kim2, Min-Cheol Lee1,  Kyung-Sub Moon1* and  Kyung-Hwa Lee1*
  • 1Chonnam National University Hwasun Hospital, South Korea
  • 2Chonnam National University Medical School, South Korea

Following the introduction of the molecular classification of gliomas by the WHO in 2016, molecularly-proven lineage conversion during glioma recurrence has never been reported. The reported two cases were initially diagnosed as oligodendroglioma with 1p/19q-codeletion and mutation of isocitrate dehydrogenase 1 (IDH1)-R132H. The recurrent tumors showed loss of alpha-thalassemia/mental retardation X-linked (ATRX) expression, strong P53 positivity, and 1p/19q-nondeletion. Next generation sequencing analysis performed on the first case confirmed the transition of molecular traits from oligodendroglioma to astrocytoma. An IDH mutation of R132H was preserved in the episodes of recurrence, but ATRX and TP53 mutations were newly acquired and TERT promoter mutation C228T was lost at the most recent recurrence. The issue in question for the presented cases is whether the original tumors were pure oligodendrogliomas that then transdifferentiated into astrocytomas, or whether the original tumor was an oligoastrocytoma having oligodendroglioma cells that outnumbered the astrocytoma cells and where the astrocytoma cells becoming more dominant over the episodes of recurrence. With the recognition of the possibility of lineage conversion, our study suggests that molecular examination should be performed to adjust therapeutic strategies in recurrent gliomas. Indeed, our observation of lineage conversion in glioma recurrence calls into question the current distinction drawn between oligodendroglioma, astrocytoma and oligoastrocytoma, rather than simply bidding “farewell to oligoastrocytoma”.

Keywords: Cell Lineage, Clonal Evolution, Genetic Heterogeneity, Mixed oligoastrocytoma, Glioma

Received: 11 Feb 2019; Accepted: 12 Aug 2019.

Copyright: © 2019 Kim, Jang, Jung, Jung, Kim, Lee, Moon and Lee. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

* Correspondence:
Prof. Kyung-Sub Moon, Chonnam National University Hwasun Hospital, Hwasun, South Korea, moonks@chonnam.ac.kr
Prof. Kyung-Hwa Lee, Chonnam National University Hwasun Hospital, Hwasun, South Korea, mdkaylee@jnu.ac.kr